SEC Form 4 · accession 0001618835-18-000080
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Colin Rutherford
Director
Period of report
Jul 31, 2018
Accepted (ET)
Aug 2, 2018 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $2.10 | Jul 31, 2018 | A | 0 | A | — | Jul 31, 2028 | Common Stock | 5,550 | 5,550 | D |
Explanation of responses
- F1The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from July 31, 2018. The option was awarded in connection with Mr. Rutherford's board and committee services.